O型血创伤患者具有独特的多组学特征:补体凝集素途径水平降低
研究前瞻性纳入符合最高级别创伤激活标准的患者,入院时采血行液相色谱-质谱蛋白质组与代谢组分析,比较O型血与其他血型患者。288例有多组学数据的患者中146例(51%)为O型血;两组人口学、损伤类型及入院生命体征和实验室检查无差异。O型血患者住院时间更长(7 vs 6天,p=0.041),创伤性脑损伤所致死亡比例有降低趋势(44.4% vs 87.5%,p=0.055),并表现为甘露糖结合凝集素及甘露糖结合凝集素相关丝氨酸蛋白酶1和2水平降低,以及提示能量代谢和线粒体功能障碍的代谢物差异。作者认为这可能使急性期补体激活和全身炎症降低、带来生存优势(尤其创伤性脑损伤),但后期可能损害愈合;未来需确认这些关联并开展动物实验检验治疗靶点。
要点
- O型血创伤患者住院时间更长(7 vs 6天,p=0.041),提示血型可能与创伤后病程相关。
- O型血患者创伤性脑损伤所致死亡比例有降低趋势(44.4% vs 87.5%,p=0.055),未达统计学显著。
- O型血患者入院时甘露糖结合凝集素及甘露糖结合凝集素相关丝氨酸蛋白酶1和2水平降低,这些蛋白为启动补体凝集素途径所必需。
- O型血患者存在提示能量代谢和线粒体功能障碍的代谢物差异。
- 作者认为急性期补体激活与全身炎症降低可能带来生存优势(尤其创伤性脑损伤),但后期可能损害愈合。
适用人群与场景
- 符合最高级别创伤激活标准的创伤患者,前瞻性纳入,入院至急诊科时采集血样。
- 比较O型血患者与其他血型患者;288例有多组学数据,其中146例(51%)为O型血。
研究设计与关键结果
- 研究类型:前瞻性纳入符合最高级别创伤激活标准患者的观察性多组学分析;288例有多组学数据,O型血146例(51%)。
- 两组人口学、损伤类型及入院生命体征和实验室检查无差异。
- O型血患者住院时间更长(7 vs 6天,p=0.041)。
- O型血患者创伤性脑损伤所致死亡比例有降低趋势(创伤性脑损伤 44.4% vs 其他原因 87.5%;p=0.055),未达统计学显著。
- O型血患者甘露糖结合凝集素及甘露糖结合凝集素相关丝氨酸蛋白酶1和2水平降低,这些蛋白为启动补体凝集素途径所必需。
- O型血患者存在提示能量代谢和线粒体功能障碍的代谢物差异。
证据类型、等级与局限
- 证据类型:前瞻性观察性多组学研究;证据等级:预后与流行病学,Level IV。
- 局限:原文未报告局限性;作者指出未来工作需确认这些关联,并需动物实验检验治疗靶点。
对床旁实践的改变
- 原文未据此给出推荐;作者认为O型血患者急性期补体激活和全身炎症降低可能带来生存优势(尤其创伤性脑损伤),但后期可能损害愈合。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Patients with type O blood may have an increased risk of hemorrhagic complications because of lower baseline levels of von Willebrand factor and factor VIII, but the transition to a mortality difference in trauma is less clear. We hypothesized that type O trauma patients will have differential proteomic and metabolomic signatures in response to trauma beyond von Willebrand factor and factor VIII alone.
METHODS: Patients meeting the highest level of trauma activation criteria were prospectively enrolled. Blood samples were collected upon arrival to the emergency department. Proteomic and metabolomic (multiomics) analyses of these samples were performed using liquid chromatography-mass spectrometry. Demographic, clinical, and multiomics data were compared between patients with type O blood versus all other patients.
RESULTS: There were 288 patients with multiomics data; 146 (51%) had type O blood. Demographics, injury patterns, and initial vital signs and laboratory measurements were not different between groups. Type O patients had increased lengths of stay (7 vs. 6 days, p = 0.041) and a trend toward decreased mortality secondary to traumatic brain injury compared with other causes (traumatic brain injury, 44.4% vs. 87.5%; p = 0.055). Type O patients had decreased levels of mannose-binding lectin and mannose-binding lectin-associated serine proteases 1 and 2, which are required for the initiation of the lectin pathway of complement activation. Type O patients also had metabolite differences signifying energy metabolism and mitochondrial dysfunction.
CONCLUSION: Blood type O patients have a unique multiomics signature, including decreased levels of proteins required to activate the lectin complement pathway. This may lead to overall decreased levels of complement activation and decreased systemic inflammation in the acute phase, possibly leading to a survival advantage, especially in traumatic brain injury. However, this may later impair healing. Future work will need to confirm these associations, and animal studies are needed to test therapeutic targets.
LEVEL OF EVIDENCE: Prognostic and Epidemiological; Level IV.
参考来源
- Stocker BW, LaCroix IS, Erickson C, et al. Trauma patients with type O blood exhibit unique multiomics signature with decreased lectin pathway of complement levels. J Trauma Acute Care Surg. 2024. PMID: 38745347. doi:10.1097/TA.0000000000004367
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。